81 related articles for article (PubMed ID: 7013027)
1. Renal transplantation and cancer in the Scandiatransplant material.
Birkeland SA; Kemp E; Hauge M
Scand J Urol Nephrol Suppl; 1980; 54():11-5. PubMed ID: 7013027
[TBL] [Abstract][Full Text] [Related]
2. Cancer as a late-onset complication of kidney transplantation.
Birkeland SA; Kemp E; Hauge M
Scand J Urol Nephrol Suppl; 1977; (42):179-83. PubMed ID: 356205
[TBL] [Abstract][Full Text] [Related]
3. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
Berg B; Möller E
Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
[No Abstract] [Full Text] [Related]
4. Malignant tumors in renal transplant patients. The Scandia transplant material.
Birkeland SA
Cancer; 1983 May; 51(9):1571-5. PubMed ID: 6339027
[TBL] [Abstract][Full Text] [Related]
5. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
6. ABH and Lewis antigens on lymphocytes: screening of pregnant women's sera with the B-cell cytotoxicity test.
Park MS; Oriol R; Nakata S; Terasaki PI; Ford R; Bernoco D
Transplant Proc; 1979 Dec; 11(4):1947-9. PubMed ID: 394439
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin.
Fabrega AJ; DeChristopher J; Sosler SD; Rivas PA; Vasquez EM; Pollak R
Clin Transplant; 1996 Apr; 10(2):166-9. PubMed ID: 8664512
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
[TBL] [Abstract][Full Text] [Related]
10. Specific anti-donor lymphocytotoxic antibodies following blood transfusion from nonrelated donors.
Ettenger RB; Jordan SC; Arnett J; Robinson BJ; Fine RN
Transplant Proc; 1982 Jun; 14(2):347-8. PubMed ID: 7051476
[No Abstract] [Full Text] [Related]
11. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
12. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
13. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
14. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
[TBL] [Abstract][Full Text] [Related]
15. Present status of ABO-incompatible kidney transplantation in Japan.
Takahashi K; Saito K
Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
[TBL] [Abstract][Full Text] [Related]
16. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
18. ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation.
Tinckam KJ; Wood IG; Ji F; Milford EL
Hum Immunol; 2004 Nov; 65(11):1281-7. PubMed ID: 15556678
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
[TBL] [Abstract][Full Text] [Related]
20. ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB).
Osorio AV; Sullivan EK; Alexander SR; Bryan CF; Shield CF; Warady BA
Pediatr Transplant; 1998 Feb; 2(1):26-9. PubMed ID: 10084756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
